Progesterone Levels and Clinical Outcomes Using a Single Pessary of 400 mg of Vaginal Progesterone in Substitutive Cycles for Embryo Transfer. — CycloCT

Luteal Phase Defect Clinical Trial

Official title:
Progesterone Levels and Clinical Outcomes Using a Single Pessary of 400 mg of Vaginal Progesterone in Substitutive Cycles for Embryo Transfer.

Status Completed

Clinical Trial Summary

This study aims to compare the efficacy, in terms of progesterone levels and clinical outcomes, of two different presentations of micronized vaginal progesterone (400 mg vs. 200 mg) used in endometrial preparation in artificial cycle (AC) for embryo transfer. This is a non-inferiority, retrospective case-control study, with at least 200 cycles analyzed (at least 100 per arm) and the primary outcome is the serum progesterone level on the day of the embryo transfer.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Luteal Phase Defect

Clinical Trial Details

NCT number	NCT04722471
Study type	Observational
Source	Instituto Bernabeu
Contact
Status	Completed
Phase
Start date	March 3, 2021
Completion date	March 17, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01178931` - Dydrogesterone Versus Intravaginal Progesterone in the Luteal Phase Support	N/A
Completed	`NCT04174378` - Luteal Phase Support In IVF Women Using GnRH Agonist
Withdrawn	`NCT02950948` - Progesterone in Luteal Phase Deficiency	Phase 3
Completed	`NCT04938622` - Bioenergetics of Exercise-Induced Menstrual Disturbances	N/A
Completed	`NCT02458404` - Effects of Varied Estrogen Doses on Endometrial Receptivity
Completed	`NCT05107804` - Energy Restriction and Hormones in Premenopausal Women	N/A
Completed	`NCT03948022` - Luteal Support in Frozen-Thawed Embryo Transfer Cycles	Phase 4
Not yet recruiting	`NCT05080569` - Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment	Phase 4
Recruiting	`NCT04806919` - Luteal Support in Artificial Vitrified/Warmed Cycles With Low Progesterone	Phase 3